Iman Adebowale
Iman Adebowale
Biography
Iman Adebowale is an associate in our global M&A and Corporate practice based in London.
She has experience advising both domestic and international clients on a broad range of public and private transactions, including mergers and acquisitions, joint ventures, private equity, equity capital markets and general corporate advisory.
Iman joined White & Case in 2021 and has completed a six-month secondment to the firm's Dubai office.
Experience
Representation of Seplat Energy on its US$1.3 billion acquisition of Mobil Producing Nigeria.
Representation of Tier Mobility on its merger with Dott, a transaction which created Europe's leading micro-mobility operator.
Representation of Cathexis L.P., a private investment holding company on the sale of Yondr Group, a global developer, owner and operator of hyperscale data centers, to DigitalBridge and La Caisse.
Representation of Gorillas, on its US$1.2 billion sale to Getir, Europe's leading q-commerce player, in a transaction valuing the combined group at US$10 billion.
Representation of Kobalt Music, the leading music and technology publishing provider, on its sale to Francisco Partners for approximately US$750 million.
Representation of Hartree Partners on its acquisition of debt and agreement to acquire ED&F Man Commodities' business units.
Representation of Southern Gas Corridor CJSC on its sale of a 5% interest in the Shah Deniz Production Sharing Agreement and a 4% interest in Azerbaijan Gas Supply Company Limited to MVM Group, the Hungarian state-owned energy company.
Representation of SOCAR on acquisition of an interest in the Umm Lulu, SARB, Bin Nasher and Al Bateel offshore concession.
Representation of Geopost SA, Europe's largest parcel delivery network and a subsidiary of La Poste Group, on the sale of its delivery platform Stuart (SRT Group) to the international investment fund Mutares.
Representation of Pan-European fintech Monese on its sale to Pockit.
Representation of ADVANZ PHARMA on its acquisition of the ex-US business of Intercept Pharmaceuticals.